<DOC>
	<DOC>NCT01703741</DOC>
	<brief_summary>This is a multicenter extension trial in adult hypogonadal males. The purpose of this study is to evaluate the safety of testosterone gel delivered using an applicator over an extended period of time.</brief_summary>
	<brief_title>A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Completion of the Phase 3 protocol (NCT01665599) Use of another investigational product Use of any medications that could be considered anabolic or interfere with androgen metabolism Use of estrogens, gonadotropin releasing hormone agonists/antagonists, antiandrogens, or human growth hormone Use of another testosterone product Chronic use of any drug of abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>